NASDAQ:AMEH • US03763A2078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APOLLO MEDICAL HOLDINGS INC (AMEH).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-02-26 | Jefferies | Initiate | Buy |
| 2024-02-22 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-01-24 | Stifel | Initiate | Buy |
| 2023-12-22 | Truist Securities | Initiate | Hold |
| 2023-10-17 | BTIG | Initiate | Buy |
| 2023-04-12 | B of A Securities | Initiate | Neutral |
| 2023-02-27 | Lake Street | Maintains | Buy |
| 2022-12-19 | Lake Street | Initiate | Buy |
| 2022-09-21 | William Blair | Initiate | Outperform |
| 2022-08-08 | Barclays | Maintains | Equal-Weight |
| 2021-08-12 | Barclays | Initiate | Equal-Weight |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 687.2M 22.58% | 773.9M 12.62% | 1.144B 47.85% | 1.398B 22.18% | 1.789B 27.97% | 2.268B 26.77% | |
| EBITDA YoY % growth | 98.85M 85.98% | 115.62M 16.97% | 121.84M 5.38% | 146.03M 19.85% | 165.43M 13.28% | 200.5M 21.20% | |
| EBIT YoY % growth | 80.5M 134.01% | 98.1M 21.86% | 104.3M 6.32% | 106.62M 2.22% | 113.07M 6.05% | 135.86M 20.16% | |
| Operating Margin | 11.71% | 12.68% | 9.12% | 7.63% | 6.32% | 5.99% | |
| EPS YoY % growth | -0.92 -348.65% | 1.57 270.65% | 1.06 -32.48% | 1.22 15.47% | 1.44 17.67% | 1.64 13.67% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 360.66% | 0.33 6.94% | 0.37 32.96% | 0.50 5.80% | 0.26 64.68% | 0.45 35.38% | 0.53 42.47% | 0.56 12.82% | 0.54 109.90% |
| Revenue Q2Q % growth | 344.06M 16.95% | 421.2M 24.91% | 430.37M 23.60% | 433.57M 24.52% | 422.63M 22.84% | 532.19M 26.35% | 536.15M 24.58% | 541.85M 24.97% | 547.67M 29.59% |
| EBITDA Q2Q % growth | 27.477M -8.84% | 38.136M 42.88% | 42.413M 19.34% | 48.04M -7.35% | 34.437M 25.33% | 48.441M 27.02% | 54.196M 27.78% | 56.075M 16.73% | 54.854M 59.29% |
| EBIT Q2Q % growth | 16.376M 29.97% | 24.513M 9.43% | 29.079M 7.70% | 39.447M 1.15% | 22.245M 35.84% | 35.496M 44.80% | 41.31M 42.06% | 43.146M 9.38% | 41.922M 88.46% |
All data in USD
12 analysts have analysed AMEH and the average price target is 47.49 USD. This implies a price increase of 16.35% is expected in the next year compared to the current price of 40.82.
APOLLO MEDICAL HOLDINGS INC (AMEH) will report earnings on 2024-02-27, after the market close.
The consensus EPS estimate for the next earnings of APOLLO MEDICAL HOLDINGS INC (AMEH) is 0.16 USD and the consensus revenue estimate is 344.06M USD.
The number of analysts covering APOLLO MEDICAL HOLDINGS INC (AMEH) is 12.